Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 33,057

Sort by:

Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2017

US$ 3,500.00

... Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 60 pages

Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) - Pipeline Review, H2 2017

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) development ...

December 2017 55 pages

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2017

US$ 3,500.00

... Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 115 pages

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2017

US$ 3,500.00

... Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 43 pages

Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) - Pipeline Review, H2 2017

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) development landscape Develop and ...

December 2017 71 pages

Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H2 2017

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) development landscape Develop and design ...

December 2017 78 pages

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2017

US$ 3,500.00

... N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 48 pages

Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2017

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) development ...

December 2017 61 pages

Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H2 2017

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) development landscape Develop ...

December 2017 38 pages

Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H2 2017

US$ 3,500.00

... Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 57 pages

Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) - Pipeline Review, H2 2017

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) development ...

December 2017 42 pages

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2017

US$ 3,500.00

... Alpha L-Iduronidase (IDUA or EC 3.2.1.76) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 48 pages

Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member 2 or SLC10A2) - Pipeline Review, H2 2017

US$ 3,500.00

... , this report also reviews key players involved in Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member 2 or SLC10A2) targeted therapeutics development with respective active and ...

December 2017 52 pages

Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) - Pipeline Review, H2 2017

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) development landscape Develop and ...

December 2017 41 pages

Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Pipeline Review, H2 2017

US$ 3,500.00

... reviews key players involved in Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) targeted therapeutics development with respective ...

December 2017 29 pages

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) - Pipeline Review, H2 2017

US$ 2,000.00

... Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

December 2017 30 pages

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H2 2017

US$ 3,500.00

... 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 50 pages

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Pipeline Review, H2 2017

US$ 3,500.00

... Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 40 pages

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) - Pipeline Review, H2 2017

US$ 3,500.00

... Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 33 pages

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2017

US$ 3,500.00

... Integrin Alpha 7 (ITGA7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 25 pages

Interleukin 1 Receptor Type 1 (CD121 Antigen Like Family Member A or Interleukin 1 Receptor Alpha or p80 or CD121a or IL1R1) - Pipeline Review, H2 2017

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Interleukin 1 Receptor Type 1 (CD121 Antigen Like Family Member A or Interleukin 1 Receptor Alpha or p80 or CD121a or IL1R1) development landscape Develop and design ...

December 2017 48 pages

LanC Like Protein 2 (Testis Specific Adriamycin Sensitivity Protein or G Protein Coupled Receptor 69B or GPR69B or LANCL2) - Pipeline Review, H2 2017

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding LanC Like Protein 2 (Testis Specific Adriamycin Sensitivity Protein or G Protein Coupled Receptor 69B or GPR69B or LANCL2) development landscape Develop and design ...

December 2017 28 pages

Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Pipeline Review, H2 2017

US$ 3,500.00

... Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 36 pages

Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) - Pipeline Review, H2 2017

US$ 3,500.00

... Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 42 pages

Muscarinic Acetylcholine Receptor M2 (CHRM2) - Pipeline Review, H2 2017

US$ 3,500.00

... Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 62 pages

Muscarinic Acetylcholine Receptor M4 (CHRM4) - Pipeline Review, H2 2017

US$ 3,500.00

... Muscarinic Acetylcholine Receptor M4 (CHRM4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 65 pages

Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) - Pipeline Review, H2 2017

US$ 3,500.00

... Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 51 pages

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Pipeline Review, H2 2017

US$ 3,500.00

... Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 50 pages

Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Pipeline Review, H2 2017

US$ 3,500.00

... Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 26 pages

Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) - Pipeline Review, H2 2017

US$ 3,500.00

... Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 110 pages

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Gamma Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Gamma or Phosphoinositide 3 Kinase Catalytic Gamma Polypeptide or Serine/Threonine Protein Kinase PIK3CG or p120 PI3K or PIK3CG or EC 2.7.11.1 or EC 2.7.1.153) - Pipeline Review, H2 2017

US$ 3,500.00

... Catalytic Subunit Gamma Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Gamma or Phosphoinositide 3 Kinase Catalytic Gamma Polypeptide or Serine/Threonine Protein Kinase PIK3CG or p120 PI3K or PIK3CG or EC 2.7.11.1 or EC 2.7.1.153) targeted therapeutics under development ...

December 2017 83 pages

Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 2.7.11.1) - Pipeline Review, H2 2017

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 2.7.11.1) development landscape Develop and ...

December 2017 45 pages

Somatostatin Receptor Type 4 (SSTR4) - Pipeline Review, H2 2017

US$ 3,500.00

... Somatostatin Receptor Type 4 (SSTR4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 37 pages

Tumor Necrosis Factor Receptor Superfamily Member 10A (Death Receptor 4 or TNF Related Apoptosis Inducing Ligand Receptor 1 or TRAIL Receptor 1 or DR4 or CD261 or TNFRSF10A) - Pipeline Review, H2 2017

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 10A (Death Receptor 4 or TNF Related Apoptosis Inducing Ligand Receptor 1 or TRAIL Receptor 1 or DR4 or CD261 or TNFRSF10A) development ...

December 2017 58 pages

Tumor Necrosis Factor Receptor Superfamily Member 10B (Death Receptor 5 or TNF Related Apoptosis Inducing Ligand Receptor 2 or TRAIL Receptor 2 or DR5 or CD262 or TNFRSF10B) - Pipeline Review, H2 2017

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 10B (Death Receptor 5 or TNF Related Apoptosis Inducing Ligand Receptor 2 or TRAIL Receptor 2 or DR5 or CD262 or TNFRSF10B) development ...

December 2017 58 pages

Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline Review, H2 2017

US$ 3,500.00

... type. It also reviews key players involved in Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) targeted therapeutics development with respective active and ...

December 2017 44 pages

Histone Lysine N Methyltransferase EHMT2 (Euchromatic Histone Lysine N Methyltransferase 2 or HLA B Associated Transcript 8 or Histone H3 K9 Methyltransferase 3 or Lysine N Methyltransferase 1C or Protein G9a or EHMT2 or EC 2.1.1.43) - Pipeline Review, H2 2017

US$ 3,500.00

Histone Lysine N Methyltransferase EHMT2 (Euchromatic Histone Lysine N Methyltransferase 2 or HLA B Associated Transcript 8 or Histone H3 K9 Methyltransferase 3 or Lysine N Methyltransferase 1C or Pro...

December 2017 30 pages

2018-2023 Asia and Regional Arterial Thrombosis Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the Asia Arterial Thrombosis Drug Market Research has the complete assessment of the ... the future outlook and prospects for Arterial Thrombosis Drug market. This report focus on Asia and regional market, providing information on major players ...

December 2017 132 pages

2018-2023 Asia and Regional Axillary Hyperhidrosis Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the Asia Axillary Hyperhidrosis Drug Market Research has the complete assessment of the ... the future outlook and prospects for Axillary Hyperhidrosis Drug market. This report focus on Asia and regional market, providing information on major players ...

December 2017 182 pages

2018-2023 Asia and Regional Chemotherapy Induced Anemia Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

... report from HNY RESEARCH on the Asia Chemotherapy Induced Anemia Drug Market Research has ... this report is to help the user understand the Chemotherapy Induced Anemia Drug market in terms of its ... and prospects for Chemotherapy Induced Anemia Drug market. This report focus on Asia and regional market, providing ...

December 2017 166 pages

2018-2023 Asia and Regional Myocardial Ischemia Drugs Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

... report from HNY RESEARCH on the Asia Myocardial Ischemia Drugs Market Research has ... this report is to help the user understand the Myocardial Ischemia Drugs market in terms of its definition, ... and prospects for Myocardial Ischemia Drugs market. This report focus on Asia and regional market, providing information ...

December 2017 143 pages

2018-2023 Asia and Regional Rhinovirus Infections Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

... report from HNY RESEARCH on the Asia Rhinovirus Infections Drug Market Research has ... this report is to help the user understand the Rhinovirus Infections Drug market in terms of its definition, ... and prospects for Rhinovirus Infections Drug market. This report focus on Asia and regional market, providing ...

December 2017 179 pages

2018-2023 China and Regional Arterial Thrombosis Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the China Arterial Thrombosis Drug Market Research has the complete assessment of the ... the future outlook and prospects for Arterial Thrombosis Drug market. This report focus on China and regional market, providing information on major players ...

December 2017 157 pages

2018-2023 China and Regional Axillary Hyperhidrosis Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the China Axillary Hyperhidrosis Drug Market Research has the complete assessment of the ... the future outlook and prospects for Axillary Hyperhidrosis Drug market. This report focus on China and regional market, providing information on major players ...

December 2017 136 pages

2018-2023 China and Regional Chemotherapy Induced Anemia Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

... report from HNY RESEARCH on the China Chemotherapy Induced Anemia Drug Market Research has ... this report is to help the user understand the Chemotherapy Induced Anemia Drug market in terms of its ... and prospects for Chemotherapy Induced Anemia Drug market. This report focus on China and regional market, providing ...

December 2017 147 pages

2018-2023 China and Regional Myocardial Ischemia Drugs Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

... report from HNY RESEARCH on the China Myocardial Ischemia Drugs Market Research has ... this report is to help the user understand the Myocardial Ischemia Drugs market in terms of its definition, ... and prospects for Myocardial Ischemia Drugs market. This report focus on China and regional market, providing ...

December 2017 161 pages

2018-2023 China and Regional Rhinovirus Infections Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

... report from HNY RESEARCH on the China Rhinovirus Infections Drug Market Research has ... this report is to help the user understand the Rhinovirus Infections Drug market in terms of its definition, ... and prospects for Rhinovirus Infections Drug market. This report focus on China and regional market, providing ...

December 2017 154 pages

2018-2023 Europe and Regional Arterial Thrombosis Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the Europe Arterial Thrombosis Drug Market Research has the complete assessment of the ... the future outlook and prospects for Arterial Thrombosis Drug market. This report focus on Europe and regional market, providing information on major players ...

December 2017 152 pages

2018-2023 Europe and Regional Axillary Hyperhidrosis Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the Europe Axillary Hyperhidrosis Drug Market Research has the complete assessment of the ... the future outlook and prospects for Axillary Hyperhidrosis Drug market. This report focus on Europe and regional market, providing information on major players ...

December 2017 131 pages

2018-2023 Europe and Regional Chemotherapy Induced Anemia Drug Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

... report from HNY RESEARCH on the Europe Chemotherapy Induced Anemia Drug Market Research ... this report is to help the user understand the Chemotherapy Induced Anemia Drug market in terms of its ... and prospects for Chemotherapy Induced Anemia Drug market. This report focus on Europe and regional market, providing ...

December 2017 192 pages

Filters

Clear all